A Role for Photobiomodulation in the Prevention of Myocardial Ischemic Reperfusion Injury: A Systematic Review and Potential Molecular Mechanisms

Abstract

Myocardial ischemia reperfusion injury is a negative pathophysiological event that may result in cardiac cell apoptosis and is a result of coronary revascularization and cardiac intervention procedures. The resulting loss of cardiomyocyte cells and the formation of scar tissue, leads to impaired heart function, a major prognostic determinant of long-term cardiac outcomes. Photobiomodulation is a novel cardiac intervention that has displayed therapeutic effects in reducing myocardial ischemia reperfusion related myocardial injury in animal models. A growing body of evidence supporting the use of photobiomodulation in myocardial infarct models has implicated multiple molecular interactions. A systematic review was conducted to identify the strength of the evidence for the therapeutic effect of photobiomodulation and to summarise the current evidence as to its mechanisms. Photobiomodulation in animal models showed consistently positive effects over a range of wavelengths and application parameters, with reductions in total infarct size (up to 76%), decreases in inflammation and scarring, and increases in tissue repair. Multiple molecular pathways were identified, including modulation of inflammatory cytokines, signalling molecules, transcription factors, enzymes and antioxidants. Current evidence regarding the use of photobiomodulation in acute and planned cardiac intervention is at an early stage but is sufficient to inform on clinical trials.

Electrical Stimulation of Dorsal Root Ganglion in the Context of Pain: A Systematic Review of In Vitro and In Vivo Animal Model Studies

“…Our findings regarding the study quality of animal studies are in agreement with other animal systematic reviews which also reported lack of randomization, blinding, insufficient evidence of random housing of the animals and inappropriate statistical analysis, which are the major factors causing bias and false positive results .…”

Low‐Intensity Photobiomodulation Decreases Neuropathic Pain in Paw Ischemia‐Reperfusion and Spared Nervus Ischiadicus Injury Experimental Models

“…Several studies have already demonstrated the therapeutic effect of low‐intensity infrared LED radiation in different IR models including hepatic injuries, skin flap ischemia, renal damage, acute myocardial infarctions, and retinal degeneration . However, none of the studies performed with different IR models focused on the effect of low‐intensity infrared LED on pain resulting from the ischemia and reperfusion procedures.…”

Noninvasive light emitting diode therapy: A novel approach for postinfarction ventricular arrhythmias and neuroimmune modulation

“…PBM, including LED and low-level laser therapy, is the low power (1-500 mW) nonthermal delivery of photons that induces a beneficial biological response in cells and tissues, 40 such as stroke 16 and traumatic brain injury. 13 PBM has been increasingly used for treatment of neuroinflammation 15 and neurodegenerative diseases.…”